Skip to main content
OpenTrials
Completed

NCT Number: NCT04797624

Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients?

The aim of this study is to analyze whether COVID-19 causes a delay in the diagnosis of gastric cancer patients particularly in the TNM staging of the tumor, or not and to compare the number of newly diagnosed patients with gastric cancer before and during the COVID-19 pandemic period.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stomach Cancer COVID-19 Corona Virus Infection Coronaviridae Infections Coronavirus Infections Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Infections Lung Diseases Neoplasms Neoplasms by Site Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Stomach Diseases Stomach Neoplasms Virus Diseases

Age range

18 year–95 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Adana City Training and Research Hospital

Adana, Yuregir, 01370, Turkey (Türkiye)

About this study

The study included the patients diagnosed with gastric cancer during the period between March 1, 2020, and December 31, 2020, in the pandemic group at the Adana City Training and Research Hospital, Department of General Surgery, Divisions of Gastroenterological Surgery and Surgical Oncology. For the baseline group, patients diagnosed with gastric cancer between January 1, 2019, and December 31, 2019, was included in the same department.

Clinical and pathological data of the patients were retrospectively collected from the hospital medical records. The following parameters were compared between the pandemic and baseline periods; age and gender distributions, mean monthly numbers of newly diagnosed patients, CEA and CEA-19.9 levels, the type of the surgery, the location of the tumor, the frequency of the patients receiving neoadjuvant treatment, American Society of Anesthesiologists (ASA) score, length of the hospital stay, clinical staging and pathologic TNM staging.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients newly diagnosed with gastric cancer at specified intervals will be included in the study.

Exclusion criteria

  • Having an additional second primary tumor

Treatment and study plan

Gastric cancer surgery

Procedure

Appropriate gastric cancer surgery types for the convenient patients

Primary outcomes

  1. Comparison of the mean monthly numbers of newly diagnosed gastric cancer patients between the groups

    Time frame: from March 1, 2020 to December 31, 2020 -from January 1, 2019 to December 31, 2019

    numbers of newly diagnosed gastric cancer

  2. Comparison of the clinical staging and pathologic TNM staging of the patients

    Time frame: from March 1, 2020 to December 31, 2020 -from January 1, 2019 to December 31, 2019

    Clinical staging was determined based on the results of a physical exam, biopsy, and imaging tests including computed tomography (CT), PET CT, endoscopy and the endoscopic ultrasound. Surgical stage refers to the pathologic stage of the surgical specimen determined based on the American Joint Committee on Cancer (AJCC) TNM system.

Secondary outcomes

  1. Comparison of the demographic data

    Time frame: from March 1, 2020 to December 31, 2020 -from January 1, 2019 to December 31, 2019

    age and gender distributions, mean monthly numbers of newly diagnosed patients, CEA and CEA-19.9 levels, the type of the surgery, the location of the tumor, the frequency of the patients receiving neoadjuvant treatment, American Society of Anesthesiologists (ASA) score, length of the hospital stay,

Sponsors and collaborators

Lead sponsor

Adana City Training and Research Hospital

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 15, 2021
Registry last updated
Mar 15, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.